A Health Economic Evaluation for Implementing an Extended Half-life Monoclonal Antibody for All Infants vs. Standard Care for Respiratory Virus Syncytial Prophylaxis in Canada
Preprint in medRxiv (March 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Preprint in medRxiv (March 2024)
Article in IJID Regions (March 2024)
Article in PLOS ONE (March 2024)